MERCK CO. DL-,01 chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 23.31
Dividend & Yield2.74€ (2.66%)
Beta 0.41
Market capitalization 261.15B
Operating cash flow 19.7B
ESG Scores 21.8

Company description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Sector: Healthcare - Industry: Drug Manufacturers—General

Financial Ratios
Quick Ratio1.02
Working Capital2.04
Return On Equity0.34
Debt To Equity0.8
Fixed Asset Ratio0.28
Fixed Interest Cover19.67

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 230M 443M 684M 405M
Total Cashflows From Investing Activities 4.31B -2.63B -9.44B -16.55B
Net Borrowings 837M 1.25B 5.01B 1.63B
Total Cash From Financing Activities -13.16B -8.86B -2.83B 2.59B
Change To Operating Activities -1.28B -250M -4.2B -997M
Issuance Of Stock 591M 361M 89M 202M
Net Income 6.22B 9.84B 7.07B 13.05B
Change In Cash 1.87B 1.97B -1.78B 14M
Effect Of Exchange Rate -205M 17M 253M -133M
Total Cash From Operating Activities 10.92B 13.44B 10.24B 14.11B
Depreciation 4.52B 3.08B 3.22B 3.12B
Change To Account Receivables -418M 92M -1B -2.03B
Other Cashflows From Financing Activities -325M 5M -436M 8.21B
Change To Netincome 1.74B 2.6B 4.56B 1.78B
Capital Expenditures -2.62B -3.37B -4.43B -4.45B

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 9.25B 8.59B 10.15B 10.2B
Income Before Tax 8.7B 7.17B 5.86B 13.88B
Net Income 6.22B 9.84B 7.07B 13.05B
Selling General Administrative 9.59B 8.83B 8.57B 9.4B
Gross Profit 28.94B 28.06B 29.96B 35.46B
Ebit 10.1B 10.64B 11.24B 15.86B
Operating Income 10.1B 10.64B 11.24B 15.86B
Interest Expense -772M -893M -831M -806M
Income Tax Expense 2.51B 1.56B 1.34B 1.52B
Total Revenue 42.29B 39.12B 41.52B 48.7B
Cost Of Revenue 13.35B 11.06B 11.55B 13.24B
Total Other Income ExpenseNet -1.4B -3.47B -5.38B -1.98B
Net Income From Continuing Ops 6.19B 5.61B 4.52B 12.36B
Net Income Applicable To Common Shares 6.22B 9.84B 7.07B 13.05B

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 55.76B 58.4B 66.18B 67.44B
Total Stockholder Equity 26.7B 25.91B 25.32B 38.18B
Other Current Liabilities 3.61B 3.15B 4.92B 3.28B
Total Assets 82.64B 84.4B 91.59B 105.69B
Common Stock 1.79B 1.79B 1.79B 1.79B
Other Current Assets 4.34B 3.95B 6.92B 5.42B
Retained Earnings 42.58B 46.6B 47.36B 53.7B
Treasury Stock -56.47B -62.14B -63.42B -61.54B
Cash 7.96B 9.68B 8.05B 8.1B
Total Current Liabilities 22.21B 22.22B 27.33B 23.87B
Other Stockholder Equity -5.54B -6.19B -6.63B -4.43B
Property, Plant, and Equipment 13.29B 16.13B 18.69B 20.86B
Total Current Assets 25.88B 27.48B 27.76B 30.27B
Net Tangible Assets -4.66B -7.71B -7.67B -6.01B
Net Receivables 7.23B 7.11B 7.24B 10.78B
Accounts Payable 4.1B 4.32B 4.67B 6.39B


Insider Transactions

Here are the insider transactions of stock shares related to MERCK CO. DL-,01:

Filer Name Transaction Text Ownership Date Filer Relation Shares
MIZELL STEVEN CSale at price 101.00 - 101.42 per share.D2022-11-10Officer35k
MIZELL STEVEN CD2022-11-10Officer35k
DAVIS ROBERT MSale at price 101.94 - 103.59 per share.D2022-11-09Chief Executive Officer167.61k
DAVIS ROBERT MConversion of Exercise of derivative security at price 62.07 per share.D2022-11-09Chief Executive Officer167.61k
OOSTHUIZEN JOHANNES JACOBUSSale at price 103.21 per share.D2022-11-09President1.79k
FRAZIER KENNETH CSale at price 98.45 - 100.07 per share.D2022-11-07Officer and Director235.77k
FRAZIER KENNETH CD2022-11-07Officer and Director235.77k
OOSTHUIZEN JOHANNES JACOBUSSale at price 99.47 per share.D2022-11-07Officer45.56k
OOSTHUIZEN JOHANNES JACOBUSConversion of Exercise of derivative security at price 62.07 - 77.62 per share.D2022-11-07Officer52.74k
FRAZIER KENNETH CSale at price 98.53 - 99.09 per share.D2022-11-04Officer and Director470k
FRAZIER KENNETH CD2022-11-04Officer and Director470k
FRAZIER KENNETH CSale at price 99.61 - 101.05 per share.D2022-11-02Officer and Director600k
FRAZIER KENNETH CD2022-11-02Officer and Director600k
FRAZIER KENNETH CStock Gift at price 0.00 per share.D2022-11-01Officer and Director5.63k
FRAZIER KENNETH CSale at price 99.15 - 101.03 per share.D2022-10-31Officer and Director867.08k
FRAZIER KENNETH CConversion of Exercise of derivative security at price 56.49 - 58.08 per share.D2022-10-31Officer and Director867.08k
MIZELL STEVEN CSale at price 98.84 - 100.00 per share.D2022-10-28Officer25k
MIZELL STEVEN CConversion of Exercise of derivative security at price 70.71 per share.D2022-10-28Officer17k
DELUCA RICHARD R JRSale at price 100.26 per share.D2022-10-28Officer164.56k
DELUCA RICHARD R JRConversion of Exercise of derivative security at price 53.06 - 58.08 per share.D2022-10-28Officer164.56k
KARACHUN RITA ASale at price 100.34 per share.D2022-10-28Officer32k
KARACHUN RITA AConversion of Exercise of derivative security at price 53.06 - 62.07 per share.D2022-10-28Officer32k
CHATTOPADHYAY SANATSale at price 100.10 per share.D2022-10-28Officer100.29k
CHATTOPADHYAY SANATConversion of Exercise of derivative security at price 43.65 - 58.08 per share.D2022-10-28Officer100.29k
ZACHARY JENNIFER LSale at price 99.07 - 99.85 per share.D2022-10-28General Counsel165.25k
ZACHARY JENNIFER LConversion of Exercise of derivative security at price 73.73 - 77.62 per share.D2022-10-28General Counsel148.65k
OOSTHUIZEN JOHANNES JACOBUSSale at price 100.21 per share.D2022-10-28Officer3.63k
OOSTHUIZEN JOHANNES JACOBUSConversion of Exercise of derivative security at price 100.77 per share.D2022-10-28Officer913
KARACHUN RITA AD2022-05-04Officer949
LECOINTE-CEPHAS LISAD2022-05-04Officer813
KLOBUCHAR MICHAEL AConversion of Exercise of derivative security at price 87.10 per share.D2022-05-04Officer885
GARAY ARPAD2022-05-04Officer907
OOSTHUIZEN JOHANNES JACOBUSD2022-05-04Officer907
KARACHUN RITA AD2022-05-03Officer902
WILLIAMS DAVID MICHAELD2022-05-03Chief Technology Officer427
LI DEAN YD2022-05-03Officer773
LECOINTE-CEPHAS LISAD2022-05-03Officer452
LITCHFIELD CAROLINED2022-05-03Chief Financial Officer773
KLOBUCHAR MICHAEL AD2022-05-03Officer773
GARAY ARPAD2022-05-03Officer773
OOSTHUIZEN JOHANNES JACOBUSD2022-05-03Officer773
KARACHUN RITA AD2022-04-29Officer928
WILLIAMS DAVID MICHAELD2022-04-29Chief Technology Officer577
LI DEAN YD2022-04-29Officer1.06k
LECOINTE-CEPHAS LISAD2022-04-29Officer640
LITCHFIELD CAROLINED2022-04-29Chief Financial Officer866
KLOBUCHAR MICHAEL AD2022-04-29Officer866
GARAY ARPAD2022-04-29Officer866
OOSTHUIZEN JOHANNES JACOBUSD2022-04-29Officer866
FRAZIER KENNETH CStock Award(Grant) at price 73.51 per share.D2022-02-24Officer and Director119.49k
MIZELL STEVEN CStock Award(Grant) at price 73.51 per share.D2022-02-24Officer14.57k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to MERCK CO. DL-,01. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on MERCK CO. DL-,01

Here is the result of two systematic investment strategies applied to MERCK CO. DL-,01. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on MERCK CO. DL-,01

The following chart shows the equity curve of the two systematic investment strategies applied to MERCK CO. DL-,01:

MERCK CO. DL-,01 automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 10.67% on the backtest period.

Performance at glance

Performance

10.67 %

Latent gain

162.34 €

Invested capital

1520.8 €

Annualized return

2.59 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on MERCK CO. DL-,01

This is the result of two momentum investment strategies applied to MERCK CO. DL-,01. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on MERCK CO. DL-,01

The following chart shows all the entries opened by the momentum investment system on MERCK CO. DL-,01:

MERCK CO. DL-,01 momentum entries
  • The first momentum investment strategy would give 14.64% of return on MERCK CO. DL-,01. That represents 859.7€ of latent gain with 5872.86€ of employed capital.
  • The second momentum investment strategy would give 10.97% of return on MERCK CO. DL-,01. That represents 556.98€ of latent gain with 5077.88€ of employed capital.
Performance at glance (1Q Momentum)

Performance

14.64 %

Latent gain

859.7 €

Invested capital

5872.86 €

Annualized return

4.76 %
Performance at glance (2Q Momentum)

Performance

10.97 %

Latent gain

556.98 €

Invested capital

5077.88 €

Annualized return

3.01 %

Momentum equity curve on MERCK CO. DL-,01

The following chart shows the equity curve of the two momentum strategies applied to MERCK CO. DL-,01:

MERCK CO. DL-,01 momentum equity

Note: the dividends potentially given by MERCK CO. DL-,01 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MERCK CO. DL-,01

The following chart shows the employed capital evolution of the two momentum strategies on MERCK CO. DL-,01 since the beginning:

MERCK CO. DL-,01

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on MERCK CO. DL-,01

Buy the dip entry openings on MERCK CO. DL-,01

MERCK CO. DL-,01

The performance achieved by the robo-advisor on MERCK CO. DL-,01 is 10.1%. That represents 73.86$ of latent gain with 731.12€ of employed capital. The following chart shows MERCK CO. DL-,01 stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of MERCK CO. DL-,01, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

10.1 %

Latent gain

73.86 €

Invested capital

731.12 €

Annualized return

4.76 %

Equity curve of the strategy applied to MERCK CO. DL-,01

The following chart shows the result of the investment strategy applied to MERCK CO. DL-,01:

MERCK CO. DL-,01

Note: the dividends potentially given by MERCK CO. DL-,01 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MERCK CO. DL-,01

The following chart shows the employed capital evolution since the beginning of the investment strategy on MERCK CO. DL-,01:

MERCK CO. DL-,01

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on MERCK CO. DL-,01

In this section, I will compare the three previous investment strategies applied to MERCK CO. DL-,01.

Equity curve comparison on MERCK CO. DL-,01

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

MERCK CO. DL-,01 investment strategy comparison

Employed capital comparison on MERCK CO. DL-,01

MERCK CO. DL-,01 investment comparison

Performance comparison on MERCK CO. DL-,01

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 10.67% 162.34€ 1520.8€ 2.59%
Momentum 1 quarter 14.64% 859.7€ 5872.86€ 3.77%
Momentum 2 quarters 10.97% 556.98€ 5077.88€ 3.01%
Non-directional 10.1% 73.86€ 731.12€ 4.76%
Annualized return comparison

Automatic investment

2.59 %

Momentum 1Q

3.01 %

Momentum 2Q

3.01 %

Non-directional

4.76 %

Correlated stocks

Here are the most positively and negatively correlated stocks with MERCK CO. DL-,01:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between MERCK CO. DL-,01 and the other stocks. There may be false positives or some missing correlated stocks. If the price of MERCK CO. DL-,01 does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name MERCK CO. DL-,01
Country United States
City Kenilworth
Address 2000 Galloping Hill Road
Phone 908 740 4000
Website www.merck.com
FullTime employees 67000
Industry Drug Manufacturers—General
Sector Healthcare
Exchange XETRA
Ticker 6MK.XETRA
Market www.xetra.com

MERCK CO. DL-,01 ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0.8
Peer Environment Performance 2.0330864197531
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 11.5
Peer Social Performance 14.299012345679
Social Percentile unknown
Highest Controversy 3
Peer Highest Controversy Performance 1.8780487804878
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic yes
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 9.6
Peer Governance Performance 8.8141975308642
Governance Percentile unknown

ESG at glance
Total ESG Scores: 21.8
Environment Score: 0.8
Social Score: 11.5
Governance Score: 9.6

ESG Performance: AVG_PERF

Peer Group: Pharmaceuticals

Peer Esg Score Performance: 25.306097560976

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 32